Nur Ink Innovations Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
NURI
IL0011757288
Specialty Chemicals
Sales 2022 | - | Sales 2023 | - | Capitalization | 53.72M 202M 4.48B |
---|---|---|---|---|---|
Net income 2022 | -11M -41.33M -917M | Net income 2023 | -12M -45.09M -1B | EV / Sales 2022 | - |
Net cash position 2022 | 17.77M 66.75M 1.48B | Net cash position 2023 | 7.22M 27.15M 603M | EV / Sales 2023 | - |
P/E ratio 2022 |
-13.6
x | P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Moshe Nur
CEO | Chief Executive Officer | 74 | 14/18/14 |
David Gerbi
DFI | Director of Finance/CFO | 44 | 26/21/26 |
Moshe Nakash
CTO | Chief Tech/Sci/R&D Officer | 60 | 09/22/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02/19/02 | |
Sarel Ashkenazi
BRD | Director/Board Member | 51 | 26/21/26 |
Moshe Nur
CEO | Chief Executive Officer | 74 | 14/18/14 |
1st Jan change | Capi. | |
---|---|---|
+10.83% | 4B | |
+5.18% | 1.75B | |
+3.44% | 979M | |
+9.13% | 966M | |
+66.88% | 752M | |
-2.47% | 692M | |
+29.53% | 600M | |
-1.29% | 553M | |
+15.68% | 499M |